Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · August 06, 2024

Mechanisms and Management of Loss of Response to Anti-TNF Therapy in Patients With Crohn's Disease

The Lancet Gastroenterology & Hepatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Gastroenterology & Hepatology
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study
Lancet Gastroenterol Hepatol 2024 Jun 01;9(6)521-538, N Chanchlani, S Lin, C Bewshea, B Hamilton, A Thomas, R Smith, C Roberts, M Bishara, R Nice, CW Lees, S Sebastian, PM Irving, RK Russell, TJ McDonald, JR Goodhand, T Ahmad, NA Kennedy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading